NFKB1 and colonic neoplasm: NF-kB was upregulated in colon cancer cell lines; otherwise, after treatment by N4-(4-phenoxyphenethyl) quinazoline-4,6-diamine (QNZ), a NF-kB inhibitor, the expression of Bcl2 was downregulated and Bax expression was upregulated.